It is documented that melatonin activates GSK3β by interfering with Akt phosphorylation to promote β-catenin breakdown and impede the EMT in a xenograft model of breast cancer metastasis [352], suggesting a circadian control of EMT in the spread of malignancies via regulation of GSK3β. This evidence concerns the gene GSK3B and breast carcinoma.